JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock (LXEO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
Lexeo Therapeutics, Inc. Common Stock
Symbol
LXEO
Shares outstanding
33,124,076 shares
Disclosed Ownership
4,339,254 shares
Ownership
13%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 11:55:21 UTC
Date of event
31 Dec 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 13% 4,339,254 0 4,339,254 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 7.6% 2,503,168 0 2,503,168 Kristin Mariani Head of North America Compliance, CCO